Robert E. George insider trades

Open-market stock purchases and sales by Robert E. George, Director at Moleculin Biotech, Inc, from SEC Form 4 filings since Sep 23, 2016.

Recent trades

DateStockTradeValue
Nov 12, 2025MBRX Moleculin Biotech, IncBought (not open market)$73.5K

Companies traded

  • MBRX Moleculin Biotech, Inc: 2 buys, last Nov 12, 2025

Get free alerts when Robert E. George files a new trade →